Novavax News

This is selected news for Novavax, which is filed under Sectors / Healthtech. There are 4.1K news items for this page. Novavax is occasionally combined with Stanley C. Erck, Stanley Erck and Ashish Jha in news items. A press release filter page is also available for Novavax.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source
12/2/2022 Novavax COVID-19 vaccine available at Pima County health clinics
Those 18 and older are eligible for the Novavax vaccine, which is approved as a primary series of two doses, three weeks apart, for those who have not yet received any other COVID-19 vaccines. Novavax is not yet authorized as a booster for people who have been vaccinated with ...
azbilingual.news
12/1/2022 Booster Now Available for Novavax
There are four options for COVID-19 immunity protection in the U.S. after the Food and Drug Administration (FDA) in October approved the first booster for Novavax, a more traditional approach to virus immunity because it is protein-based. Novavax takes a more traditional approach to virus immunity because it ...
heartlanddailynews.com
12/1/2022 What Vaccinations Do I Need To Travel To The United States?
... States are: - Janssen/J&J - Convidacea (Cancinobio) The two-dose vaccines available for travel to the United States are: - Komirneti (Pfizer-BioNTech) - nail wax (modern) - Novavax - Komirneti (Pfizer-BioNTech) - nail wax (modern) - Vaxjaveria (AstraZeneca) - Covaxin - covishield - BIBP/Sinopharm - CoronaVac (Synovac) - Nuvaxovid (Novavax) - kovovax What does it mean to have a ...
nationworldnews.com
12/1/2022 Cetera Advisor Networks LLC Boosts Stock Position in Novavax, Inc. (NASDAQ:NVAX) - Ticker Report
Cetera Advisor Networks LLC boosted its holdings in shares of Novavax, Inc. ( NASDAQ:NVAX ‚Ai Get Rating ) by 86.0% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 14,763 shares of the biopharmaceutical company's stock after ...
Ticker Report
12/1/2022 Cetera Advisor Networks LLC Raises Stock Holdings in Novavax, Inc. (NASDAQ:NVAX)
Cetera Advisor Networks LLC raised its position in shares of Novavax, Inc. (NASDAQ:NVAX ‚Ai Get Rating) by 86.0% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 14,763 shares of the biopharmaceutical company's stock after purchasing an ...
etfdailynews.com
12/1/2022 Novavax, Inc. (NASDAQ:NVAX) Shares Purchased by Korea Investment CORP - Ticker Report
Korea Investment CORP grew its holdings in shares of Novavax, Inc. ( NASDAQ:NVAX ‚Ai Get Rating ) by 596.4% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,875 shares of the biopharmaceutical company's stock after buying an ...
Ticker Report
12/1/2022 USS Investment Management Ltd Trims Position in Novavax, Inc. (NASDAQ:NVAX) - Ticker Report
USS Investment Management Ltd cut its holdings in shares of Novavax, Inc. ( NASDAQ:NVAX ‚Ai Get Rating ) by 15.2% during the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 5,314 shares of the biopharmaceutical company's stock after selling 950 shares during the quarter. USS Investment Management Ltd's ...
Ticker Report
12/1/2022 Novavax, Inc. (NASDAQ:NVAX) Shares Acquired by Virtus ETF Advisers LLC - Ticker Report
Virtus ETF Advisers LLC grew its position in Novavax, Inc. ( NASDAQ:NVAX ‚Ai Get Rating ) by 190.9% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,679 shares of the biopharmaceutical company's stock after acquiring an additional 1,758 shares ...
Ticker Report
12/1/2022 Novavax, Inc. (NASDAQ:NVAX) Shares Purchased by Virtus ETF Advisers LLC - Watch List News
Virtus ETF Advisers LLC boosted its holdings in Novavax, Inc. ( NASDAQ:NVAX ‚Ai Get Rating ) by 190.9% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 2,679 shares of the biopharmaceutical company's stock after buying an ...
watchlistnews.com
11/30/2022 Central Casting (Georgia, USA) THE RESIDENT ON FOX – NOW CASTING MINOR PHOTO DOUBLE! Filming in Conyers, GA
... eligible for a Booster according to CDC guidelines (click here to check if you are eligible for Booster) (Also: if you received the AstraZeneca and Novavax vaccines, then three doses of any combination of Pfizer, Moderna, Johnson & Johnson, AstraZeneca, or Novavax vaccines would deem you Boosted) or (B) fully vaccinated ...
thesoutherncastingcall.com
11/30/2022 Novavax (NASDAQ:NVAX) Stock Price Up 4.7%
Novavax, Inc. (NASDAQ:NVAX ‚Ai Get Rating) shares rose 4.7% on Monday . The company traded as high as $17.36 and last traded at $17.32. Approximately 11,374 shares were traded during trading, a decline of 100% from the average daily volume of 5,701,016 shares. The stock had previously closed at $16.54 ...
baseballnewssource.com
11/30/2022 Novavax (NASDAQ:NVAX) Trading Up 4.7%
Novavax, Inc. (NASDAQ:NVAX ‚Ai Get Rating)'s share price was up 4.7% during mid-day trading on Monday . The company traded as high as $17.36 and last traded at $17.32. Approximately 11,374 shares changed hands during trading, a decline of 100% from the average daily volume of 5,701,016 shares ...
zolmax.com
11/30/2022 Ulta stock rises on bullish call from Citi
Yahoo Finance Live's Brian Sozzi discusses the rise in stock for Ulta after a Citi analyst's bullish call. Investors may be reacting to positive short-term news, but a longer-term development also provided them with a boost of confidence. Investors need to pay close attention to Novavax ...
Yahoo News
11/30/2022 Novavax Stock Drops By 28% In The Last 10 Sessions
VIANEWS) ‚Ai Shares of Novavax (NASDAQ: NVAX) fell by a staggering 28.98% in 10 sessions from $23.22 at 2022-11-15, to $16.49 at 16:25 EST on Wednesday, after two successive sessions in a row of gains. NASDAQ is rising 4.41% to $11,468.00, after three consecutive sessions in a row of losses ...
via.news
11/30/2022 Novavax Inc. [NVAX] Stock trading around $16.83 per share: What's Next?
Industry Novavax Inc. [NVAX] Stock trading around $16.83 per share: What's Next? By Edison Baldwin - November 30, 2022 Facebook Twitter Pinterest Novavax Inc. [NASDAQ: NVAX] closed the trading session at $16.83 on 11/29/22. The day's price range saw the stock hit a low of $16.36, while the highest ...
dbtnews.com
11/30/2022 Novavax (NASDAQ:NVAX) Hits New 1-Year Low at $15.86 - Stock Observer
Shares of Novavax, Inc. ( NASDAQ:NVAX ‚Ai Get Rating ) reached a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $15.86 and last traded at $16.07, with a volume of 29930 shares changing hands. The stock had previously closed at $16.83. Analysts Set ...
thestockobserver.com
11/30/2022 Novavax (NASDAQ:NVAX) Sets New 52-Week Low at $15.86
Novavax, Inc. (NASDAQ:NVAX ‚Ai Get Rating)'s stock price hit a new 52-week low during mid-day trading on Wednesday . The company traded as low as $15.86 and last traded at $16.07, with a volume of 29930 shares trading hands. The stock had previously closed at $16.83. Analyst ...
The Markets Daily
11/30/2022 Novavax (NASDAQ:NVAX) Hits New 1-Year Low at $15.86
Shares of Novavax, Inc. (NASDAQ:NVAX ‚Ai Get Rating) reached a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $15.86 and last traded at $16.07, with a volume of 29930 shares changing hands. The stock had previously closed at $16.83. Analysts Set ...
Dakota Financial News
11/30/2022 Novavax (NVAX) COVID Jab Gets Expanded Label in WHO's EUL
Novavax, Inc. NVAX announced that the World Health Organization (‚AuWHO‚Au) updated the emergency use listing (‚AuEUL‚Au) of its COVID-19 vaccine, NVX-CoV2373. Following this update, NVX-CoV2373 is now included in WHO's EUL for use as a primary series in adults and adolescents aged 12 years ...
Nasdaq
11/30/2022 Regulatory actions for Nov. 30, 2022
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aldeyra, Ascletis, Buchang, Capstone, Caribou, Genentech, Gilead, Kala, Novavax, Remd, Sofie ...
BioWorld
11/29/2022 üíâ COVID-19 Novavax Nuvaxovid COVID-19 Vaccine | dispatchist.com
Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced , a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that Health Canada has granted expanded authorization for Nuvaxovid‚N¢ (COVID-19 Vaccine (Recombinant ...
dispatchist.com
11/29/2022 Does Novavax Inc. (NVAX) offer a good opportunity for investors?
Novavax Inc. (NASDAQ: NVAX) stock jumped 0.60% on Monday to $16.64 against a previous-day closing price of $16.54. With 3.4 million shares changed hands, the volume of the stock remained lighter than its average volume of 4.87 million shares. During the session, the Biotechnology company that operates in wider ...
setenews.com
11/29/2022 Franklin Resources Inc. Sells 1,727 Shares of Novavax, Inc. (NASDAQ:NVAX) - Ticker Report
Franklin Resources Inc. lowered its stake in shares of Novavax, Inc. ( NASDAQ:NVAX ‚Ai Get Rating ) by 0.7% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 235,885 shares of the biopharmaceutical company's stock after selling ...
Ticker Report
11/29/2022 Franklin Resources Inc. Lowers Position in Novavax, Inc. (NASDAQ:NVAX)
Franklin Resources Inc. cut its stake in Novavax, Inc. (NASDAQ:NVAX ‚Ai Get Rating) by 0.7% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 235,885 shares of the biopharmaceutical company's stock after selling 1,727 shares during ...
baseballnewssource.com
11/29/2022 Grantham Mayo Van Otterloo & Co. LLC Takes $345,000 Position in Novavax, Inc. (NASDAQ:NVAX) - Ticker Report
Grantham Mayo Van Otterloo & Co. LLC acquired a new stake in Novavax, Inc. ( NASDAQ:NVAX ‚Ai Get Rating ) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 6,700 shares of the biopharmaceutical company's ...
Ticker Report